- CardiAQ Valve Technologies taps former CoreValve COO Michiels as CEO
CardiAQ Valve Technologies announced that it has appointed former CoreValve president and COO Rob Michiels, 61, CEO effective immediately. Michiels will remain a director of CVT and founding CEO Brent Ratz will remain a director and president of CVT, adding COO to his roster of titles.
- Cook Medical promotes Rusty Burns to VP, global logistics and purchasing
Rusty Burns, a 31-year veteran of Cook Inc., was promoted to VP of global logistics and purchasing. In his new role, Burns will manage all of Cook’s global warehousing, distribution and materials management services, which play an integral role in ensuring timely delivery of Cook products to customers worldwide.
Food & Drug commissioner Dr. Margaret Hamburg named her office’s top lawyer, John Taylor III, to be the temporary replacement for outgoing deputy commish Dr. Joshua Sharfstein.
Taylor, counselor to the commissioner will take on the new role Jan. 10, an FDA spokeswoman told MassDevice. Sharfstein’s last day on the job is Jan. 7.
Sharfstein, formerly Baltimore’s top public health official, is slated to be named secretary of health and mental hygiene for Maryland by Gov. Martin O’Malley.
When Medtronic Inc. (NYSE:MDT) CEO Art Collins retired in 2007, there were at least two candidates vying to replace him.
One was Michael DeMane, the brash president of Fridley, Minn.-based medical device giant’s spine business whose aggressive pursuit of growth invited legal and regulatory scrutiny. The other was chief operating officer Bill Hawkins, a steady, stabilizing presence within Medtronic’s senior leadership team.
UPDATED Dec. 20, 10:22 a.m.
Medtronic Inc. (NYSE:MDT) chairman and CEO William Hawkins plans to step down at the end of April 2011 after what would be nearly four years at the helm of one of the world’s largest medical device makers.
The Fridley, Minn.-based medical device monolith didn’t give a reason for Hawkins’ departure in a press release and senior media relations director Brian Henry stayed coy when asked for the reasons behind the move.
- Pulmatrix taps Eva Jack as chief business officer
Pulmatrix announced the appointment of Eva Jack as chief business officer. In this newly created position, Ms. Jack will provide strategic leadership as the Company begins business development efforts around its portfolio of proprietary inhaled cationic airway lining modulator drugs and pulmonary drug delivery platform.
William Caldwell IV, the chairman and CEO of Advanced Cell Technology Inc. (OTC:ACTC), died suddenly Dec. 13. He was 63.
Marlborough, Mass.-based ACT said Caldwell had been CEO since 2005 and chairman since 2006.
Just a day after Eden Prairie, Minn.-based SurModics Inc. (NSDQ:SRDX), said it would formally respond to Ramius LLC’s efforts to name three people to its board of directors, the company announced it had named a new CEO and would explore a sale of its pharmaceuticals business.
- Sonova announces that Cameron Hay is standing down as president and CEO of Unitron Hearing
Cameron Hay is leaving Sonova Holding AG after over five years as a member of the Management Board to take on new professional and personal challenges outside the Group. Sonova Holding AG will appoint his successor shortly.